STOCK MARKET BSE NSE

COVID-19: New milestone in Covaxin trials as 32 candidates get booster shots

This is the second shot of the vaccine and will show how safe this vaccine is on human beings. The first one was administered in July.

Published: 13th August 2020 08:49 AM  |   Last Updated: 13th August 2020 08:58 AM   |  A+A-

'COVAXIN' was developed and manufactured at the company's Bio-safety Level-III high containment facility at Genome Valley.

'COVAXIN' was developed and manufactured at the company's Bio-safety Level-III high containment facility at Genome Valley.  (Photo| Special Arrangement)

By Express News Service

HYDERABAD: India’s Covid-19 vaccine candidate Covaxin by Bharat Biotech reached a new milestone in trials. On Tuesday and Wednesday, booster shots were given to 32 of the 50 candidates for trial.

This is the second shot of the vaccine and will show how safe this vaccine is on human beings. The first one was administered in July.

“We are in the middle of the Phase-I trial which will last for one more month. This week is crucial as we have administered the booster dose. We have been monitoring the patients on a weekly basis by checking their BP, heart rate, and other indices. We have also been using telemedicine facilities to monitor them,” said a senior doctor involved in the study.

In Phase-I, two shots are administered to each of the 50-odd patients, the objective is to see how safe the vaccine is.

“The idea is to look for fever, rashes or other conditions, which may appear as a reaction to the vaccine. In Phase-II, how many vaccines must be given to have an antibody response in the patients will be determined,” added another doctor.

In this phase, the antibody- Titers’ or level of antibodies generated in the patient’s body will be examined.

More from Nation.

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp